Hints and tips:
Related Special Reports
Plus: outsourcers tap into remote work boom; Shopify targets more growth from bigger clients; Brazil’s alternative to electric vehicles; and Vertex Pharmaceutical’s potential answer to the opioid crisis
...Companies, including US-based Eli Lilly, Vertex Pharmaceuticals and BeiGene in Switzerland, have been talking with rival contract manufacturers to diversify production away from WuXi companies, according...
...So effective is Vertex Pharmaceuticals’ blockbuster cystic fibrosis (CF) drug, Trikafta, that studies project it could extend the lives of some young patients by up to 45 years....
...the AXA IM Framlington Biotech fund, compared the vaccine companies with others that have had a standout year because of a single drug, such as Gilead with its hepatitis C medicine and, to some extent, Vertex...
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
...Vertex Pharmaceuticals leapt 13.2 per cent to a record high of $405.07....
...The therapy — Casgevy, developed by US biotech company Vertex Pharmaceuticals and Crispr Therapeutics for the blood disorders sickle cell disease and beta thalassaemia — has since been approved by the European...
...The FDA approved Casgevy, a treatment developed by Vertex Pharmaceuticals and Crispr Therapeutics. The FDA’s approval includes Casgevy and Bluebird Bio’s therapy called Lyfgenia....
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, now called Casgevy, which was developed by Vertex pharmaceuticals and Crispr Therapeutics....
...The two biotech companies at the forefront of developing the therapy are CRISPR Therapeutics and Vertex Pharmaceuticals....
...There is no medical school in this country that has fully incorporated AI.”...
...“We are showing how cancer genomics can be incorporated into mainstream cancer care across a national health system and the benefits that can bring patients.”...
...Pharmaceuticals Q4, Vodafone Q3 trading update Tuesday Australia: Reserve Bank of Australia interest rate announcement EU: December retail sales figures Germany: January factory orders data UK: BRC-KPMG...
...It was then licensed to and launched by Vertex, the Boston-based pharmaceutical company....
...“What is needed is an exports council to deliver a joined-up policy to support trade which should be incorporated into the body delivering an overarching industrial strategy here in the UK,” he added....
...Pfizer, the pharmaceutical group, is challenging an Oregon shareholder proposal at the SEC. The company declined to comment....
...Its predictions will be incorporated into the widely used Ensembl Variant Effect Predictor run by the European Bioinformatics Institute in Cambridge. AlphaMissense has limitations, Avsec said....
...The therapy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics, will be used for the treatment of sickle cell disease and beta thalassaemia....
...“The odds that we wake up and see a J&J or Lilly do something big like buying Alnylam, Incyte or Vertex goes down from where it would have been,” said Stifel’s Opler....
...The product, developed by Vertex Pharmaceuticals and Crispr Therapeutics of the US, corrects the gene defect that causes sickle cell disease, a blood disorder....
...But no one today thinks that pharmaceutical companies should be allowed to market unlicensed drugs because we all accept that the potential damage far outweighs the restrictions and bureaucracy....
...Liverpool’s zone seeks to boost its existing pharmaceutical cluster, with ministers encouraged by a £10mn investment recently committed by TriRx to expand its plant....
...The NHS has agreed, for example, to prescribe certain expensive but transformative treatments such as Novartis’ Zolgensma, which treats spinal muscular atrophy, and Orkambi, a drug made by US biotech Vertex...
...An important test is on the horizon with the anticipated approval next year in the US of a gene therapy targeting sickle cell disease, which has been developed by Vertex Pharmaceuticals and Crispr Therapeutics...
...It may have incorporated Dark Sky’s next-hour rain forecasts and it may have a lot of colourful graphics and more data....
International Edition